Jenkem Technology Co Ltd (688356) - Total Liabilities

Latest as of September 2025: CN¥81.71 Million CNY ≈ $11.96 Million USD

Based on the latest financial reports, Jenkem Technology Co Ltd (688356) has total liabilities worth CN¥81.71 Million CNY (≈ $11.96 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jenkem Technology Co Ltd (688356) asset resilience to evaluate the company's liquid asset resilience ratio.

Jenkem Technology Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Jenkem Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 688356 current and non-current assets.

Jenkem Technology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jenkem Technology Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Liberty Gold Corp
TO:LGD
Canada CA$5.22 Million
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
USA $95.42 Million
Dynavox Group
ST:DYVOX
Sweden Skr1.91 Billion
Aussie Broadband Ltd
AU:ABB
Australia AU$511.64 Million
Minerals 260 Ltd
AU:MI6
Australia AU$16.95 Million
Sunrise Group Co Ltd
SHE:002752
China CN¥3.97 Billion
Jiangsu Sanfangxiang Industry Co Ltd
SHG:600370
China CN¥12.02 Billion
Luzerner Kantonalbank AG
LSE:0QNU
UK £59.66 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Jenkem Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Jenkem Technology Co Ltd (688356) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 9.68 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.06 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jenkem Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jenkem Technology Co Ltd (2016–2024)

The table below shows the annual total liabilities of Jenkem Technology Co Ltd from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥100.51 Million
≈ $14.71 Million
+53.64%
2023-12-31 CN¥65.42 Million
≈ $9.57 Million
-15.92%
2022-12-31 CN¥77.80 Million
≈ $11.38 Million
+57.01%
2021-12-31 CN¥49.55 Million
≈ $7.25 Million
+11.69%
2020-12-31 CN¥44.37 Million
≈ $6.49 Million
-7.76%
2019-12-31 CN¥48.10 Million
≈ $7.04 Million
+0.93%
2018-12-31 CN¥47.66 Million
≈ $6.97 Million
+60.04%
2017-12-31 CN¥29.78 Million
≈ $4.36 Million
-0.45%
2016-12-31 CN¥29.91 Million
≈ $4.38 Million
--

About Jenkem Technology Co Ltd

SHG:688356 China Specialty Chemicals
Market Cap
$882.19 Million
CN¥6.03 Billion CNY
Market Cap Rank
#9582 Global
#2472 in China
Share Price
CN¥99.40
Change (1 day)
+9.11%
52-Week Range
CN¥62.39 - CN¥133.41
All Time High
CN¥382.67
About

Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, … Read more